Home › Funds › Velan Capital Investment Management LP › ARTV
Velan Capital Investment Management LP position in ARTV
LATIGO BIOTHERAPEUTICS INC · Health Care
Velan Capital Investment Management LP reported holding 25,000 shares of ARTV (LATIGO BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$178K, representing 0.17% of its reported portfolio and ranking #36 among its reported holdings. Velan Capital Investment Management LP has disclosed ARTV holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Velan Capital Investment Management LP's ARTV position evolved
Velan Capital Investment Management LP first disclosed a stake in ARTV in Q1 2026 at 25,000 shares (US$161K). The position peaked in Q2 2026 at 25,000 shares, worth US$242K. Across 3 filings, Velan Capital Investment Management LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 25,000 shares valued at US$178K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 25.00K | $161.00K | New |
| Q2 2026 | 25.00K | $242.50K | Hold |
| Q3 2026 | 25.00K | $178.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARTV and 13F data
ARTV (LATIGO BIOTHERAPEUTICS INC) is a Health Care company. 82 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$174.2M), Deep Track Capital, LP (US$73.6M), Blue Owl Capital Holdings LP (US$63.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARTV
- RA CAPITAL MANAGEMENT, L.P. 17.96M sh · $174.17M · Q2 2026
- Deep Track Capital, LP 4.41M sh · $73.62M · Q3 2026
- Blue Owl Capital Holdings LP 4.13M sh · $63.84M · Q3 2026
- 5AM Venture Management, LLC 2.35M sh · $22.83M · Q2 2026
- Venrock Adviser, LLC 2.04M sh · $19.82M · Q2 2026
- Caligan Partners LP 1.74M sh · $16.84M · Q2 2026
- Sanofi 672.78K sh · $11.24M · Q3 2026
- Samsara BioCapital, LLC 954.86K sh · $9.26M · Q2 2026
- Saturn V Capital Management LP 300.36K sh · $5.02M · Q3 2026
- Propel Bio Management, LLC 696.44K sh · $4.96M · Q3 2026
- Revelation Capital Management, LLC 299.31K sh · $2.13M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 260.42K sh · $1.85M · Q3 2026
More on Velan Capital Investment Management LP
FAQ
How long has Velan Capital Investment Management LP held ARTV?
Velan Capital Investment Management LP has disclosed ARTV holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Velan Capital Investment Management LP's current position in ARTV?
As of Q3 2026, Velan Capital Investment Management LP holds 25.00K shares of ARTV (LATIGO BIOTHERAPEUTICS INC), valued at $178.00K, representing 0.17% of its reported portfolio and ranking #36.
Has Velan Capital Investment Management LP been buying or selling ARTV?
In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in ARTV. The position peaked in Q2 2026 at 25.00K shares.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., Deep Track Capital, LP, Blue Owl Capital Holdings LP, among 82 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.